Market cap
$1.16T
Price as of
2026-10-29
Latest filing
8-K · 2026-10-20
Alerts
8
Price$266.48 +1.35% 3M daily closessample
268.74244.64
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 23INS
- Oct 20SEC
- Oct 15INS
- Oct 09INS
- Oct 01INS
- Sep 22INS
- Sep 11INS
- Sep 03INS
Company facts
SEC EDGAR registration- Name
- Beam Therapeutics Inc.
- Sector
- Healthcare
- Industry
- Biotechnology
- Smart-money score
- +31sample, -100 to +100
- Reporting currency
- USD
Who is positioning in BEAM
sample- Insiders
- 33 insider transactions over 90 days, net selling, $477.3M
- Congress
- No member trades over 90 days
- Institutions · 13F
- 7 funds hold $24.3B
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$34.0B +11.0% y/y
Q4 2024Q3 2026
Inventory$20.1B +8.3% y/y
Q4 2024Q3 2026
Accounts receivable$16.1B +22.4% y/y
Q4 2024Q3 2026
Total debt$41.6B +9.6% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $315.0B -1.2% 3M
- Sample peer B
- $718.0B -3.9% 3M
- Sample peer C
- $927.6B +16.4% 3M
- Sample peer D
- $1.13T -0.8% 3M
- Sample peer E
- $311.5B +9.8% 3M